SPHK2 and metabolic dysfunction-associated steatotic liver disease: To examine the role of SphK2 in the development of NAFLD-HCC, we fed wild-type (WT) and Sphk2-KO mice an HFHSD for 46 weeks in the absence of any chemical carcinogens.